Funded Startups in Yerushalayim
The disclosed-largest round in this Yerushalayim-focused list is Future Meat’s $347M (Series B) on 2021-12-17, which dwarfs the rest of the disclosed amounts.
The disclosed-largest round in this Yerushalayim-focused list is Future Meat’s $347M (Series B) on 2021-12-17, which dwarfs the rest of the disclosed amounts. The next-largest disclosed rounds include OrCam Technologies at $181M (2024-07-28) and Lightricks at $100M (2021-09-19), but neither approaches $347M.
Rounds also cluster around specific “close dates” and stages. Half the entries with a specific stage label are concentrated in a biotech/health cluster: biotechnology and health care each appear multiple times (e.g., Omnix Medical $25M on 2025-10-13; Senseera Health $7M on 2025-01-07; OurCrowd $25M on 2021-10-27). Stage classification is also frequently non-standard: “Series Unknown” appears 9 times and “undisclosed” appears 3 times, with examples like OrCam Technologies $181M (2024-07-28, Series Unknown) and Omnivox? (not present) GynTools $30K (2024-06-06, Series Unknown). The dataset spans 2020-02-26 (Strattic) through 2025-10-13 (Omnix Medical), and the most recent row is Omnix Medical’s $25M (Series C) on 2025-10-13.
Most recent rounds
41 shownRelated listings
Frequently asked
What stands out in the size distribution of disclosed rounds across this Yerushalayim list?
Future Meat’s $347M (Series B) on 2021-12-17 is the main outlier; the next-largest disclosed rounds shown are OrCam Technologies at $181M (2024-07-28) and Lightricks at $100M (2021-09-19). Several other rounds sit far lower (for example, multiple entries at $25M like Omnix Medical on 2025-10-13 and OurCrowd on 2021-10-27).
Do entries cluster in time rather than being evenly spread?
There are visible bursts: 2024 includes several rounds close together on 2024-06-06 (GynTools $30K; Hydro X $30K), and there are also back-to-back 2021 mid-year events like 2021-06-01 (VOTIS Subdermal Imaging Technologies $3M) and 2021-06-11 (Diptera.ai $3M). The overall span is still wide, running from 2020-02-26 to 2025-10-13, so these clusters occur within a broader timeline.
Which stage labels dominate, and how often are amounts tied to missing/unknown classification?
“Series Unknown” is the most frequent explicit label, appearing 9 times (e.g., OrCam Technologies $181M on 2024-07-28; Nectin Therapeutics $10M on 2022-05-06; WISESIGHT is undisclosed on 2022-12-18). “Undisclosed” amounts appear 3 times, including Joyned on 2023-12-14 and Olive Diagnostics on 2023-03-09.
Are any sectors over-represented relative to others in this list?
Biotechnology and health-related work recur more than single-appearance categories. Examples of biotechnology include Omnix Medical ($25M, 2025-10-13), Nectin Therapeutics ($10M, 2022-05-06), KAHR medical ($13M, 2022-11-17), and Future Meat ($347M, 2021-12-17). Health Care also shows repeated entries such as Senseera Health ($7M, 2025-01-07) and EyeYon ($25M, 2021-03-15).
Do any geographic patterns appear beyond the “Yerushalayim” label?
Multiple entries use the same city naming convention (Jerusalem, Yerushalayim, Israel) as the majority, but there are also distinct sub-areas and nearby localities. For example, several rounds list Neve Ilan (Illumigyn $33M on 2021-11-03; Nanox Imaging $59M on 2020-07-28), while others list Beit-shemesh (Viewbix $5M on 2025-07-11) and Beit Neqofa (Air Doctor $20M on 2024-10-01).
What are the smallest disclosed rounds, and do they signal a different risk/seed profile than the largest rounds?
The smallest disclosed amounts are $100K, each tied to Pre-Seed entries: Privatise ($100K, 2021-02-23) and SolidBlock ($100K, 2021-02-04). These are orders of magnitude below the disclosed highs (Future Meat at $347M on 2021-12-17), suggesting a sharp spread from very early financing to later, large-scale rounds within the same geography-focused list.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.